James Mahon

8PUBLICATIONS

24CO-AUTHORS

Counselling, wellbeing and community servicesMolecular targetsAvionicsMedical biotechnology diagnostics (incl. biosensors)Neural engineering

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jun 29, 2026

Digital front door technologies to pre-assess people before assessment for NHS Talking Therapies [HTE10055]: early value assessment.

|Sep 10, 2024

Lenvatinib plus pembrolizumab for untreated advanced renal cell carcinoma: a systematic review and cost-effectiveness analysis.

Nigel Fleeman, Rachel Houten, Sarah Nevitt

|Dec 05, 2023

Correction: Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15.

Marty Chaplin, Rebecca Bresnahan, Nigel Fleeman

|Oct 15, 2023

Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation.

Rebecca Bresnahan, Rui Duarte, James Mahon

|Sep 21, 2023

Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15.

Marty Chaplin, Rebecca Bresnahan, Nigel Fleeman

|May 17, 2023

Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Rebecca Bresnahan, Rachel Houten, Janette Greenhalgh

Pageof 2

Frequent Collaborators

Angela Boland

Sophie Beale

Rachel Houten

Nigel Fleeman

Marty Chaplin

Yenal Dundar

Rebecca Bresnahan

Janette Greenhalgh

Sarah Nevitt

Katherine Edwards

Frequent Collaborators

Angela Boland

Sophie Beale

Rachel Houten

Nigel Fleeman